Literature DB >> 10710339

Single-channel activity and expression of atrial L-type Ca(2+) channels in patients with latent hyperthyroidism.

U Kreuzberg1, P Theissen, H Schicha, F Schröder, U Mehlhorn, E R de Vivie, P Bokník, J Neumann, C Grohé, S Herzig.   

Abstract

Patients with "latent hyperthyroidism" (suppressed thyroid-stimulating hormone and normal circulating thyroid hormones) are at risk to develop atrial fibrillation. In animal models, hyperthyroidism is associated with increased cardiac L-type Ca(2+) current. Therefore, we assessed L-type channel function and expression in right atria from patients undergoing cardiac surgery. Single L-type channels were studied in the cell-attached condition. Voltage dependence of gating was similar in patients with and without latent hyperthyroidism. With use of a pulse protocol leading to maximum channel availability, single-channel activity was further analyzed. Average peak current was significantly enhanced in latent hyperthyroidism, mainly because of an increased channel availability (P < 0.05). Protein expression was analyzed by Western blot. In latent hyperthyroidism, expression of Ca(2+) channel alpha(1)-subunits was increased more than threefold (P < 0.01). In contrast, sarco(endo)plasmic reticulum Ca(2+)-ATPase and phospholamban levels were not significantly changed. We only observed a trend toward increased sarco(endo)plasmic reticulum Ca(2+)-ATPase expression (P = 0.085). Function and expression of human atrial L-type Ca(2+) channels are increased in latent hyperthyroidism. These endocrine effects on the heart may be clinically relevant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10710339     DOI: 10.1152/ajpheart.2000.278.3.H723

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  9 in total

1.  Cellular localization of voltage-gated calcium channels and synaptic vesicle-associated proteins in the guinea pig cochlea.

Authors:  Maria G Layton; Donald Robertson; Alan W Everett; Wilhelmina H A M Mulders; Graeme K Yates
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

2.  Heart rate reduction with ivabradine prevents thyroid hormone-induced cardiac remodeling in rat.

Authors:  Bo Hyun Kim; Kyoung Im Cho; Seong Man Kim; Nari Kim; Jin Han; Jee Yeon Kim; In Ju Kim
Journal:  Heart Vessels       Date:  2012-11-11       Impact factor: 2.037

3.  Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats.

Authors:  Youhua Zhang; Eduard I Dedkov; Diana Teplitsky; Nathan Y Weltman; Christine J Pol; Viswanathan Rajagopalan; Bianca Lee; A Martin Gerdes
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-09-14

4.  The effects of ischemic postconditioning on myocardial function and nitric oxide metabolites following ischemia-reperfusion in hyperthyroid rats.

Authors:  Jalal Zaman; Sajjad Jeddi; Asghar Ghasemi
Journal:  Korean J Physiol Pharmacol       Date:  2014-12-30       Impact factor: 2.016

5.  Functional Effects of Hyperthyroidism on Cardiac Papillary Muscle in Rats.

Authors:  Fabricio Furtado Vieira; Robson Ruiz Olivoto; Priscyla Oliveira da Silva; Julio Cesar Francisco; Rosalvo Tadeu Hochmuller Fogaça
Journal:  Arq Bras Cardiol       Date:  2016-12       Impact factor: 2.000

6.  Alterations of protein expression of phospholamban, ZASP and plakoglobin in human atria in subgroups of seniors.

Authors:  Ulrich Gergs; Winnie Mangold; Frank Langguth; Mechthild Hatzfeld; Steffen Hauptmann; Hasan Bushnaq; Andreas Simm; Rolf-Edgar Silber; Joachim Neumann
Journal:  Sci Rep       Date:  2019-04-04       Impact factor: 4.379

Review 7.  The Role of Thyroid Diseases and their Medications in Cardiovascular Disorders: A Review of the Literature.

Authors:  Negar Omidi; Mohammadrafie Khorgami; Farbod Z Tajrishi; Amirhosein Seyedhoseinpour; Parichehr Pasbakhsh
Journal:  Curr Cardiol Rev       Date:  2020

8.  Hyperthyroidism, but not hypertension, impairs PITX2 expression leading to Wnt-microRNA-ion channel remodeling.

Authors:  Estefanía Lozano-Velasco; Rosemary Wangensteen; Andrés Quesada; Carlos Garcia-Padilla; Julia A Osorio; María Dolores Ruiz-Torres; Amelia Aranega; Diego Franco
Journal:  PLoS One       Date:  2017-12-01       Impact factor: 3.240

9.  Levothyroxine treatment generates an abnormal uterine contractility patterns in an in vitro animal model.

Authors:  Stéphanie Corriveau; Simon Blouin; Évelyne Raiche; Marc-Antoine Nolin; Éric Rousseau; Jean-Charles Pasquier
Journal:  J Clin Transl Endocrinol       Date:  2015-09-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.